Abstract
Stimulus control induced by (-)-2,5-dimethoxy-4-methylamphetamine (DOM) is believed to be mediated by agonism at 5-HT2A receptors. We hypothesized that blockade of (-) DOM-induced stimulus control may thus prove useful in the pre-clinical characterization of novel antipsychotic agents by providing an in vivo index of antagonism at that receptor. A previous study (Fiorella et al., 1995a) observed no antagonism by typical agents such as haloperidol and thioridazine, partial antagonism by the atypical agent, clozapine, and full antagonism by risperidone, a second atypical antipsychotic. The present investigation extends these observations to include seven additional drugs: SCH 23390, sulpiride, amperozide, melperone, octoclothepin, tiospirone and ritanserin. Of the drugs tested in rats in which (-) DOM-induced stimulus control had reliably been established, only tiospirone and ritanserin produced complete antagonism of the (-) DOM stimulus. Intermediate levels of antagonism were observed following treatment with amperozide, melperone, and octoclothepin. Finally, SCH 23390 and sulpiride yielded no evidence of antagonistic activity in (-) DOM-trained animals. Because clozapine and risperidone are both classified as atypical antipsyc...Continue Reading
References
Jan 1, 1976·Schizophrenia Bulletin·H Y Meltzer, S M Stahl
Jan 1, 1992·Psychopharmacology·D E Casey
Jul 1, 1991·Journal of Medicinal Chemistry·K P BøgesøH Pedersen
Jan 1, 1991·Schizophrenia Bulletin·H Y Meltzer
Jan 1, 1991·Schizophrenia Bulletin·J Gerlach
Jan 1, 1991·Psychopharmacology·R AxelssonA Björk
Jan 1, 1990·Pharmacology & Toxicology·J Svartengren, P Simonsson
Jan 1, 1989·Acta Psychiatrica Scandinavica. Supplementum·L Bjerkenstedt
Sep 1, 1986·Neuropharmacology·F J White, R Y Wang
Dec 1, 1986·Journal of Clinical Psychopharmacology·H Y MeltzerD J Luchins
Dec 1, 1985·Pharmacology, Biochemistry, and Behavior·R A Glennon, A E Hauck
Jan 1, 1987·Synapse·D Clark, F J White
Jan 1, 1988·Psychopharmacology·E B Nielsen
Jan 1, 1988·Synapse·J P WalshN A Buchwald
May 18, 1984·European Journal of Pharmacology·R B MailmanD L Dehaven
Feb 1, 1994·Neuroscience·R L Gellman, G K Aghajanian
Oct 13, 1994·European Journal of Pharmacology·R SchreiberM J Millan
Feb 1, 1994·Psychopharmacology·F A WieselB Eriksson
Oct 1, 1995·Psychopharmacology·D FiorellaJ C Winter
Citations
Feb 8, 2005·Psychopharmacology·Scott D PhilibinJoseph H Porter
Nov 8, 2008·Psychopharmacology·Scott D PhilibinJoseph H Porter
Jan 30, 2002·Psychiatry Research·H Y MeltzerK Jayathilake
Sep 20, 2005·Behavioural Pharmacology·A J PrusJ H Porter